The allogeneic liver transplantation. I. Morphological and functional patterns in pig liver allografts (author's transl)

Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
H Bockhorn

Abstract

Pigs usually reject MHC incompatible liver allografts less aggressively than skin or kidney allografts. Orthotopic liver allografts can survive undefinitely without any immunosuppression. The liver is considered to be an immunologically privileged organ. Despite this phenomenon, morphological changes and deranged liver function due to rejection reaction are regularly seen; their intensity depends on the histocompatibility antigen disparity between donor and recipient. In long-term survivors the continuous exposure of the recipient's immune system to the liver allograft results in an increasing fibrosis which can turn into liver cirrhosis being considered as the result of chronic rejection. The cholestasis represents a remarkable feature, which is mainly due to perfusion, infection and immunological reaction.

References

Feb 19, 1977·British Medical Journal·R Y Calne, R Williams
May 1, 1976·British Medical Bulletin·R Y Calne
Nov 8, 1972·Nature: New Biology·B A BradleyR Y Calne
Aug 2, 1972·Nature: New Biology·J Dausset, J Hors
Oct 7, 1972·British Medical Journal·R A Sinclair
Nov 1, 1972·Transplantation·M VaimanP Nizza
Oct 1, 1972·Transplantation·D P De Bono
Dec 16, 1967·British Medical Journal·R Y CalneD R Davis
Apr 1, 1968·The Journal of Surgical Research·J TerblancheK E Hobbs
Jan 15, 1969·Klinische Wochenschrift·A Bohle, K Hinrichsen
Oct 1, 1969·British Journal of Anaesthesia·G G HarrisonJ Terblanche
Nov 17, 1962·Nature·J L GOWANSD M COWEN

❮ Previous
Next ❯

Citations

Feb 1, 1984·The Journal of Surgical Research·J J VisserH F Hoitsma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.